Cannabidiol May Interfere With Common Cancer Drugs, Study Warns

Researchers have identified significant drug-drug interactions between cannabidiol (CBD) and standard chemotherapy treatments, raising safety concerns for cancer patients using both simultaneously. The findings could reshape clinical guidance on CBD use during cancer treatment and prompt healthcare systems to screen for potential conflicts.

Originaltitel: Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics